Related Experiment Video

Updated: Aug 22, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Advances in pediatric allergy

Kelly D Stone1

  • 1Division of Immunology, Children's Hospital Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. kstone@cnmc.org

Current Opinion in Pediatrics
|September 16, 2004
PubMed

Insights

Recent research highlights advances in pediatric allergic diseases, including asthma and food allergies. Understanding environmental factors and improving management strategies are key for better treatment outcomes in children.

Area of Science:

  • Pediatric Allergy and Immunology
  • Atopic Disease Research
  • Clinical Pediatrics

Background:

  • Allergic disorders significantly impact pediatric healthcare.
  • Understanding the etiology and natural history of pediatric allergies is crucial.
  • Effective management strategies are essential for affected children.

Purpose of the Study:

  • To review significant findings in pediatric allergic diseases over the past year.
  • Focus on asthma, urticaria, food allergy, and vaccine reactions in children.
  • Highlight progress in understanding and managing these conditions.

Main Methods:

  • Literature review of recent studies (past year) on pediatric allergic diseases.
  • Analysis of findings related to environmental exposures, disease management, and treatment.
  • Synthesis of data from large population reports and vaccine reaction databases.

Main Results:

  • Progress in identifying early-life environmental exposures linked to atopic diseases like asthma.
  • Challenges in managing chronic urticaria in children, with new data on idiopathic and cold urticaria.
  • Increasing prevalence of food allergies, with ongoing improvements in diagnosis and management; report on vaccine anaphylaxis cases.

Conclusions:

  • Continued advancements in understanding pediatric allergic diseases.
  • Availability of effective treatments for most pediatric allergic conditions.
  • Emphasizing patient and parent education for optimal management and reduced restrictions.
Abstract

More Related Videos

Basophil Activation Test for Allergy Diagnosis07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...